Thrombolytic therapy administered longer after the onset of ischemic stroke than current recommendations did not demonstrate improved clinical outcomes as compared to placebo, according to a recent trial published in the ...
Mar 8, 2024
0
11
In a clinical report issued by the American Academy of Pediatrics and published online Sept. 19 in Pediatrics, recommendations are presented to help guide pediatricians and other clinicians in the assessment of bleeding disorders ...
Oct 3, 2022
0
8
A multi-center study of more than 3,000 people with high blood pressure and brain aneurysms found that the use of RAAS inhibitors, a class of blood pressure lowering medications, reduced the risk of an aneurysm rupture by ...
Jun 3, 2022
0
10
Researchers at the National Cerebral and Cardiovascular Center in Japan found that patients aged ≥75 years with non-valvular atrial fibrillation (NVAF) and previous stroke/transient ischemic attack (TIA) more commonly had ...
Apr 21, 2022
0
8
Extremely preterm infants have a significant risk of death or severe intracranial hemorrhage in the first seven days of life.
Feb 3, 2022
0
6
A three-year study of more than 1,000 patients found that the risk of delayed intracranial hemorrhage and death following head trauma was significantly higher for adults taking older blood thinning medications including clopidogrel ...
Nov 30, 2021
0
31
The largest multi-institutional international study to date on brain complications of COVID-19 has found that approximately one in 100 patients hospitalized with COVID-19 will likely develop complications of the central nervous ...
Nov 29, 2021
0
8
Clot-busting drugs are the main treatment for stroke, but they have often not been recommended for people who have an aneurysm in their brains that has not ruptured. An aneurysm is a bulge in the wall of a blood vessel in ...
Oct 6, 2021
0
37
Ever since the coronavirus became a wide-spread global pandemic, medical researchers have sought to understand how the virus impacts other medical ailments, especially neurological ones. In early 2020, New York's Mount Sinai ...
Apr 29, 2021
0
62
(HealthDay)—For extremely preterm infants, high-dose erythropoietin treatment from 24 hours after birth does not result in a reduced risk for severe neurodevelopmental impairment or death at age 2 years, according to a ...
Jan 16, 2020
0
2
